Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (431-440 of 706) with videos related to

Pageof 71
Sort By:
The American Journal of Medicine|August 29, 2012
Predictors of adherence to performance measures in patients with acute myocardial infarctionDharam J Kumbhani, Gregg C Fonarow, Christopher P Cannon, et al.
Journal of the American College of Cardiology|November 1, 2023
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1cRahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
Circulation|March 17, 2005
Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatmentMarc S Sabatine, Gavin J Blake, Mark H Drazner, et al.
American Heart Journal|November 27, 2008
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristicsRobert E Ratner, Christopher P Cannon, Hertzel C Gerstein, et al.
JACC. Cardiovascular Interventions|December 7, 2019
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and DiabetesMichael Maeng, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|August 24, 2019
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT TrialArman Qamar, Robert P Giugliano, Erin A Bohula, et al.
Heart (British Cardiac Society)|June 25, 2014
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromesChristoph Varenhorst, Ulrica Alström, Oscar Ö Braun, et al.
Circulation. Cardiovascular Quality and Outcomes|September 6, 2012
Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarctionKeith A Somma, Deepak L Bhatt, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|April 23, 2003
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18David A Morrow, James A de Lemos, Marc S Sabatine, et al.
JAMA Cardiology|March 15, 2017
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT TrialRobert P Giugliano, Stephen D Wiviott, Michael A Blazing, et al.
Pageof 71

Showing results (431-440 of 706) with videos related to

Sort By:
Pageof 71
The American Journal of Medicine|August 29, 2012
Predictors of adherence to performance measures in patients with acute myocardial infarctionDharam J Kumbhani, Gregg C Fonarow, Christopher P Cannon, et al.
Journal of the American College of Cardiology|November 1, 2023
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1cRahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
Circulation|March 17, 2005
Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatmentMarc S Sabatine, Gavin J Blake, Mark H Drazner, et al.
American Heart Journal|November 27, 2008
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristicsRobert E Ratner, Christopher P Cannon, Hertzel C Gerstein, et al.
JACC. Cardiovascular Interventions|December 7, 2019
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and DiabetesMichael Maeng, Philippe Gabriel Steg, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|August 24, 2019
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT TrialArman Qamar, Robert P Giugliano, Erin A Bohula, et al.
Heart (British Cardiac Society)|June 25, 2014
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromesChristoph Varenhorst, Ulrica Alström, Oscar Ö Braun, et al.
Circulation. Cardiovascular Quality and Outcomes|September 6, 2012
Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarctionKeith A Somma, Deepak L Bhatt, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|April 23, 2003
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18David A Morrow, James A de Lemos, Marc S Sabatine, et al.
JAMA Cardiology|March 15, 2017
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT TrialRobert P Giugliano, Stephen D Wiviott, Michael A Blazing, et al.
Pageof 71